Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Obser... by Nadia Guezour, Ghassen Soussi, Solenn Brosseau, Baptiste Abbar, Charles Naltet, Charles Vauchier, Nicolas Poté, Lorry Hachon, Céline Namour, Antoine Khalil, Jean Trédaniel, Gérard Zalcman, Valérie Gounant

Get full text